Table 2.
Characteristics of A. baumannii strains caused meningitis in neuro-ICU in 2013–2020.
| Case | Strain | ST | KL | OCL | AMR Phenotype | AM gr. | ARP |
|---|---|---|---|---|---|---|---|
| #1 | B-8162 | 2 | 9 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN, TET, NIT | 9 | XDR |
| #2 | B-9371 | 2 | 9 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN, NIT | 8 | XDR |
| #3 | B-9374 | 2 | 9 | 1 | AG, CAR, FQN, CEF, PEN, TET, CM, NIT | 8 | MDR |
| #4 | B-8161 | 2 | 9 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN, TET, CM, NIT | 10 | XDR |
| #5 | B-9378 | 45 | 77 | 1 | AG, CAR, FQN, CEF, PEN, PEN-IN, CM, NIT | 8 | MDR |
| #6 | B-9379 | 2 | 9 | 1 | AG, CAR, FQN, CEF, SUL, PEN, TET, CM, NIT | 9 | MDR |
| #7 | B-9380 | 2 | 2 | 1 | AG, FQN, CEF, PEN, PEN-IN, TET, CM, NIT | 8 | MDR |
| #8 | B-9381 | 2 | 9 | 1 | AG, CAR, FQN, CEF, PEN, PEN-IN, CM, NIT | 8 | MDR |
| #9 | B-9387 | 1 | 17 | 1 | AG, CAR, FQN, CEF, PEN, TET, CM, NIT | 8 | XDR |
| #10 | B-9389 | 2 | 9 | 1 | AG, CAR, FQN, CEF, SUL, PEN, CM, NIT | 8 | MDR |
| #11 | B-10836 | 2 | 9 | 1 | AG, CAR, FQN, CEF, PEN, PEN-IN, CM, NIT | 8 | MDR |
| #12 | B-9390 | 78 | 49 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN, CM, NIT | 9 | MDR |
| #13 | B-9391 | 2 | 9 | 1 | AG, CAR, FQN, CEF, SUL, PEN, TET, CM, NIT | 9 | XDR |
| #14 | B-9395 | 2 | 165 | 1 | AG, FQN, CEF, PEN, PEN-IN, CM, NIT | 7 | MDR |
| #15 | B-9397 | 2 | 213 | 1 | AG, FQN, CEF, PEN, PEN-IN, POL, NIT | 7 | MDR |
| #16 | B-9398 | 2 | 2 | 1 | AG, FQN, CEF, SUL, PEN, PEN-IN, POL, NIT | 8 | MDR |
| #17 | B-8158 | 45 | 9 | 1 | AG, FQN, CEF, PEN, POL, CM | 6 | MDR |
| #18 | B-9399 | 2 | 213 | 1 | AG, FQN, CEF, PEN, PEN-IN, TET, CM, NIT | 8 | MDR |
| #19 | B-9396 | 1 | 4 | 1 | AG, FQN, CEF, SUL, PEN, PEN-IN, CM, NIT | 8 | MDR |
| #20 | B-9400 | 1 | 4 | 1 | AG, FQN, CEF, SUL, PEN, PEN-IN, CM, NIT | 8 | MDR |
| #21 | B-9401 | 19 | 91 | 5 | AG, FQN, CEF, SUL, PEN, PEN-IN, CM, NIT | 8 | MDR |
| #22 | B-9402 | 2 | 3 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN, TET, CM, NIT | 10 | XDR |
| #23 | B-9403 | 2 | 9 | 1 | AG, CAR, FQN, CEF, PEN, CM, NIT | 7 | MDR |
| #24 | B-9404 | 106 | 104 | 6 | CEF, SUL, PEN, PEN-IN, CM, NIT | 6 | MDR |
| #25 | B-9405 | 2 | 235 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN | 7 | MDR |
| #26 | B-9406 | 400 | 15 | 1 | AG, FQN, CEF, SUL, PEN-IN | 6 | MDR |
| #27 | B-9407 | 2 | 235 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN | 7 | MDR |
| #28 | B-9408 | 78 | 3 | 1 | CAR, FQN, CEF, SUL, PEN, PEN-IN | 6 | MDR |
| #29 | B-9409 | 19 | 91 | 5 | CAR, FQN, CEF, SUL, PEN, PEN-IN | 6 | MDR |
| #30 | B-9410 | 2 | 9 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN, TET | 8 | XDR |
| #31 | B-9411 | 2 | 3 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN, TET | 8 | XDR |
| #32 | B-9412 | 2 | 9 | 1 | CAR, FQN, CEF, PEN, PEN-IN, NIT | 6 | MDR |
| #33 | B-9413 | 78 | 15 | 1 | CAR, FQN, CEF, SUL, PEN, PEN-IN | 6 | MDR |
| #34 | B-9414 | 19 | 91 | 5 | AG, FQN, CEF, SUL, PEN, PEN-IN | 6 | MDR |
| #35 | B-9415 | 2 | 2 | 1 | AG, CAR, FQN, CEF, SUL PEN, | 6 | MDR |
| #36 | B-9416 | 2 | 49 | 1 | AG, CAR, FQN, CEF, SUL, PEN, POL | 7 | MDR |
| #37 | B-9417 | 2 | 9 | 1 | AG, CAR, FQN, CEF, SUL, PEN, PEN-IN | 7 | MDR |
Note: ST, sequence type; CL, capsular locus type; OCL, lipooligosaccharide outer core locus type; AMR, antimicrobial resistance phenotype; AM gr., number of antimicrobial groups (resistance); ARP, antimicrobial resistance patterns [21]; AG, aminoglycosides; CAR, carbapenems; FQN, fluoroquinolones; CEF, cephalosporins; SUL, sulfonamides; PEN, penicillin; PEN-IN, penicillin/beta-lactam inhibitors; TET, tetracyclines; CM, phenicols (chloramphenicol); POL, polymyxins; NIT, nitrofurans; MDR, multidrug resistant; XDR, extensively drug resistant.